Inventor · disambiguated record
Christopher M. Adams
Also filed as: ADAMS CHRISTOPHER · ADAMS CHRISTOPHER C · ADAMS CHRISTOPHER M · ADAMS CHRISTOPHER MICHAEL
31 granted patents·15 pending applications·217 citations·filing 2001–2023
96Inventor score
Files withNOVARTIS AG13UNIV IOWA RES FOUND10ADAMS CHRISTOPHER MICHAEL9ADAMS CHRISTOPHER M5ADAMS CHRISTOPHER4
Top patents by PatentIndex Score
46 records- 0196US9056874B2Complement pathway modulators and uses thereofADAMS CHRISTOPHER MICHAEL·Filed 2013·Granted Jun 16, 2015·95 cites·29 claims
- 0295US9254295B2Tomatidine, analogs thereof, compositions comprising same, and uses for sameUNIV IOWA RES FOUND·Filed 2015·Granted Feb 9, 2016·27 cites·8 claims
- 0394US10751417B2Sustained release delivery systems comprising traceless linkersNOVARTIS AG·Filed 2018·Granted Aug 25, 2020·11 cites·9 claims
- 0490US9295664B2Methods for lowering blood glucoseADAMS CHRISTOPHER M·Filed 2012·Granted Mar 29, 2016·17 cites·2 claims
- 0589US9682968B2Piperidinyl-indole derivatives complement factor B inhibitors and uses thereofADAMS CHRISTOPHER MICHAEL·Filed 2014·Granted Jun 20, 2017·15 cites·17 claims
- 0688US8030334B2Organic compoundsNOVARTIS AG·Filed 2009·Granted Oct 4, 2011·9 cites·13 claims
- 0787US10137136B2Methods for inhibiting muscle atrophyUNIV IOWA RES FOUND·Filed 2016·Granted Nov 27, 2018·6 cites·20 claims
- 0886US11090313B2Methods for inhibiting muscle atrophyUNIV IOWA RES FOUND·Filed 2019·Granted Aug 17, 2021·4 cites·21 claims
- 0985US10093663B2Piperidinyl-indole derivatives complement factor B inhibitors and uses thereofNOVARTIS AG·Filed 2017·Granted Oct 9, 2018·5 cites·18 claims
- 1084US10537563B2Methods for treating ocular disease using inhibitors of CSF-1RNOVARTIS AG·Filed 2017·Granted Jan 21, 2020·2 cites·19 claims
- 1182US10668087B2Methods for inhibiting muscle atrophyUNIV IOWA RES FOUND·Filed 2018·Granted Jun 2, 2020·1 cites·20 claims
- 1282US10576091B2Tomatidine, analogs thereof, compositions comprising same, and uses for sameUNIV IOWA RES FOUND·Filed 2018·Granted Mar 3, 2020·1 cites·25 claims
- 1382US10022386B2Tomatidine, analogs thereof, compositions comprising same, and uses for sameUNIV IOWA RES FOUND·Filed 2015·Granted Jul 17, 2018·1 cites·25 claims
- 1481US9676728B22-benzyl-benzimidazole complement factor B inhibitors and uses thereofADAMS CHRISTOPHER·Filed 2014·Granted Jun 13, 2017·6 cites·12 claims
- 1580US9475806B2Complement factor B inhibitors and uses there ofADAMS CHRISTOPHER MICHAEL·Filed 2014·Granted Oct 25, 2016·6 cites·14 claims
- 1677US12433949B2Sustained release delivery systems comprising traceless linkersNOVARTIS AG·Filed 2022·Granted Oct 7, 2025·0 cites·7 claims
- 1777US9856204B2Methods for inhibiting muscle atrophyADAMS CHRISTOPHER M·Filed 2011·Granted Jan 2, 2018·5 cites·20 claims
- 1875US2024269149A1Methods for inhibiting muscle atrophyUNIV IOWA RES FOUND·Filed 2023·Application pending·0 cites
- 1974US8846656B2Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5a receptor modulatorsADAMS CHRISTOPHER MICHAEL·Filed 2012·Granted Sep 30, 2014·2 cites·3 claims
- 2074US8791141B2Organic compoundsADAMS CHRISTOPHER·Filed 2009·Granted Jul 29, 2014·1 cites·9 claims
- 2174US8436035B2Organic compoundsADAMS CHRISTOPHER·Filed 2007·Granted May 7, 2013·2 cites·9 claims
- 2270US8153674B2Organic compoundsADAMS CHRISTOPHER·Filed 2007·Granted Apr 10, 2012·1 cites·12 claims
- 2367US2022280535A1Methods for inhibiting muscle atrophyUNIV IOWA RES FOUND·Filed 2021·Application pending·0 cites
- 2464US2022323595A1Sustained delivery of angiopoetin-like 3 polypeptidesNOVARTIS AG·Filed 2022·Application pending·0 cites
- 2562US2020376129A1Sustained release delivery systems comprising traceless linkersNOVARTIS AG·Filed 2020·Application pending·0 cites
- 2661US2025115572A1Spirocyclic piperidinyl derivatives as complement factor b inhibitors and uses thereofNOVARTIS AG·Filed 2023·Application pending·0 cites
- 2761US2014288126A1Organic compoundsADAMS CHRISTOPHER MICHAEL·Filed 2014·Application pending·0 cites
- 2854US9242963B2Organic compoundsADAMS CHRISTOPHER MICHAEL·Filed 2015·Granted Jan 26, 2016·0 cites·11 claims
- 2953US9505755B2Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5A receptor modulatorsADAMS CHRISTOPHER MICHAEL·Filed 2014·Granted Nov 29, 2016·0 cites·11 claims
- 3052US10550102B2Indane and indoline derivatives and the use thereof as soluble guanylate cyclase activatorsNOVARTIS AG·Filed 2018·Granted Feb 4, 2020·0 cites·15 claims
- 3151US11389541B2Sustained delivery of angiopoetin-like 3 polypeptidesNOVARTIS AG·Filed 2019·Granted Jul 19, 2022·0 cites·18 claims
- 3251US2014275175A1Organic compoundsADAMS CHRISTOPHER MICHAEL·Filed 2014·Application pending·0 cites
- 3351US2004058356A1Methods for global profiling gene regulatory element activityFiled 2003·Application pending·0 cites
- 3448US2014371188A1Compositions and methods for inhibiting muscle atrophy and inducing muscle hypertrophyUNIV IOWA RES FOUND·Filed 2012·Application pending·0 cites
- 3548US2022257596A1Methods for treating meibomian gland dysfunction with liver x receptor agonistsNOVARTIS AG·Filed 2020·Application pending·0 cites
- 3645US10208018B2Indane and indoline derivatives and the use thereof as soluble guanylate cyclase activatorsADAMS CHRISTOPHER M·Filed 2015·Granted Feb 19, 2019·0 cites·18 claims
- 3745US2018118657A1Methods for inhibiting muscle atrophyUNIV IOWA RES FOUND·Filed 2017·Application pending·0 cites
- 3844US8778972B25-pyridin-3-yl-1, 3-dihydro-indol-2-on derivatives and their use as modulators of aldosterone synthase and/or CYP11B1HU QI-YING·Filed 2010·Granted Jul 15, 2014·0 cites·9 claims
- 3943US10174006B2Topical aqueous ophthalmic compositions containing a 1H-indole-1-carboxamide derivative and use thereof for treatment of ophthalmic diseaseNOVARTIS AG·Filed 2014·Granted Jan 8, 2019·0 cites·18 claims
- 4042US2011237444A1Methods of mapping genomic methylation patternsLIFE TECHNOLOGIES CORP·Filed 2010·Application pending·0 cites
- 4140US10316020B2Indane derivatives and the use thereof as soluble guanylate cyclase activatorsNOVARTIS AG·Filed 2016·Granted Jun 11, 2019·0 cites·18 claims
- 4240US2004214183A1Methods for global profiling gene regulatory element activityFiled 2002·Application pending·0 cites
- 4340US2015250767A1Complement pathway modulators and uses thereofADAMS CHRISTOPHER MICHAEL·Filed 2015·Application pending·0 cites
- 4434US2004048262A1Methods for determining the bilogical effects of compounds on gene expressionFiled 2001·Application pending·0 cites
- 4532US9765067B2Thiophen-2-yl-pyridin-2-yl-1H-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activatorsADAMS CHRISTOPHER M·Filed 2015·Granted Sep 19, 2017·0 cites·19 claims
- 4631US9957254B2Cyclohexen-1-yl-pyridin-2-yl-1h-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activatorsADAMS CHRISTOPHER M·Filed 2015·Granted May 1, 2018·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Christopher M. Adams files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →